Related Experiment Video

Updated: Jun 7, 2026

Cutaneous Leishmaniasis in the Dorsal Skin of Hamsters: a Useful Model for the Screening of Antileishmanial Drugs
11:36

Cutaneous Leishmaniasis in the Dorsal Skin of Hamsters: a Useful Model for the Screening of Antileishmanial Drugs

Published on: April 21, 2012

Myeloculture in patients with cutaneous lichmaniasis under treatment

J ARANHA CAMPOS

    Revista Paulista De Medicina
    |October 29, 2010
    PubMed
    Abstract

    No abstract available in PubMed .

    Keywords:
    LEISHMANIASIS/therapy

    More Related Videos

    In Vivo Infection with Leishmania amazonensis to Evaluate Parasite Virulence in Mice
    06:57

    In Vivo Infection with Leishmania amazonensis to Evaluate Parasite Virulence in Mice

    Published on: February 20, 2020

    Related Experiment Videos

    Last Updated: Jun 7, 2026

    Cutaneous Leishmaniasis in the Dorsal Skin of Hamsters: a Useful Model for the Screening of Antileishmanial Drugs
    11:36

    Cutaneous Leishmaniasis in the Dorsal Skin of Hamsters: a Useful Model for the Screening of Antileishmanial Drugs

    Published on: April 21, 2012

    In Vivo Infection with Leishmania amazonensis to Evaluate Parasite Virulence in Mice
    06:57

    In Vivo Infection with Leishmania amazonensis to Evaluate Parasite Virulence in Mice

    Published on: February 20, 2020

    Related Concept Videos

    Leishmaniasis01:30

    Leishmaniasis

    Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
    Antiprotozoal Agents01:21

    Antiprotozoal Agents

    Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...

    Articles linked to this work by shared authors, journal, and citation graph.

    Progress in Synthesis and Pharmacology of Telmisartan.

    Chemistry & biodiversity·2026

    Functional psychosurgery in psychiatry: indications and preoperative evaluation. A narrative review.

    Frontiers in psychiatry·2026

    Development of humanized mouse models for the preclinical evaluation of NK cell-based therapies.

    Frontiers in immunology·2026

    Focused Ultrasound is Poised to Take Non-Viral Gene Therapies to the Blood-Brain Barrier - and Beyond.

    Cell biomaterials·2026

    pAc/Emm55 increases anti-melanoma immunity via TLR2 signaling in dendritic cells and improves checkpoint blockade efficacy.

    Frontiers in immunology·2026

    Exposure-response and dose simulation of belantamab mafodotin in combination with standards of care in patients with relapsed/refractory multiple myeloma.

    Haematologica·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us